nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Budesonide—ulcerative colitis	0.109	0.257	CbGbCtD
Pimecrolimus—CYP3A4—Methylprednisolone—ulcerative colitis	0.0488	0.115	CbGbCtD
Pimecrolimus—CYP3A4—Nicotine—ulcerative colitis	0.0475	0.112	CbGbCtD
Pimecrolimus—CYP3A4—Cholecalciferol—ulcerative colitis	0.0426	0.1	CbGbCtD
Pimecrolimus—CYP3A4—Triamcinolone—ulcerative colitis	0.037	0.0868	CbGbCtD
Pimecrolimus—CYP3A4—Betamethasone—ulcerative colitis	0.0317	0.0745	CbGbCtD
Pimecrolimus—CYP3A4—Prednisolone—ulcerative colitis	0.0313	0.0735	CbGbCtD
Pimecrolimus—CYP3A4—Hydrocortisone—ulcerative colitis	0.0297	0.0697	CbGbCtD
Pimecrolimus—CYP3A4—Prednisone—ulcerative colitis	0.0295	0.0694	CbGbCtD
Pimecrolimus—CYP3A4—Dexamethasone—ulcerative colitis	0.0184	0.0433	CbGbCtD
Pimecrolimus—MTOR—epithelium—ulcerative colitis	0.00359	0.123	CbGeAlD
Pimecrolimus—MTOR—smooth muscle tissue—ulcerative colitis	0.00346	0.119	CbGeAlD
Pimecrolimus—FKBP1A—epithelium—ulcerative colitis	0.00323	0.111	CbGeAlD
Pimecrolimus—FKBP1A—smooth muscle tissue—ulcerative colitis	0.00311	0.107	CbGeAlD
Pimecrolimus—MTOR—lymphoid tissue—ulcerative colitis	0.00276	0.095	CbGeAlD
Pimecrolimus—MTOR—digestive system—ulcerative colitis	0.00273	0.0939	CbGeAlD
Pimecrolimus—FKBP1A—lymphoid tissue—ulcerative colitis	0.00248	0.0855	CbGeAlD
Pimecrolimus—FKBP1A—digestive system—ulcerative colitis	0.00245	0.0844	CbGeAlD
Pimecrolimus—MTOR—liver—ulcerative colitis	0.00203	0.0699	CbGeAlD
Pimecrolimus—FKBP1A—liver—ulcerative colitis	0.00183	0.0629	CbGeAlD
Pimecrolimus—Temsirolimus—ABCB1—ulcerative colitis	0.00138	0.272	CrCbGaD
Pimecrolimus—Tacrolimus—ALB—ulcerative colitis	0.00127	0.25	CrCbGaD
Pimecrolimus—Tacrolimus—ABCB1—ulcerative colitis	0.00121	0.239	CrCbGaD
Pimecrolimus—Sirolimus—ABCB1—ulcerative colitis	0.00121	0.239	CrCbGaD
Pimecrolimus—CYP3A4—digestive system—ulcerative colitis	0.000802	0.0276	CbGeAlD
Pimecrolimus—CYP3A4—liver—ulcerative colitis	0.000597	0.0206	CbGeAlD
Pimecrolimus—Erythema—Mesalazine—ulcerative colitis	0.000502	0.00146	CcSEcCtD
Pimecrolimus—Diarrhoea—Nicotine—ulcerative colitis	0.0005	0.00145	CcSEcCtD
Pimecrolimus—Infection—Budesonide—ulcerative colitis	0.0005	0.00145	CcSEcCtD
Pimecrolimus—Nervous system disorder—Budesonide—ulcerative colitis	0.000494	0.00143	CcSEcCtD
Pimecrolimus—Skin disorder—Budesonide—ulcerative colitis	0.000489	0.00142	CcSEcCtD
Pimecrolimus—Back pain—Mesalazine—ulcerative colitis	0.000485	0.00141	CcSEcCtD
Pimecrolimus—Asthma—Triamcinolone—ulcerative colitis	0.000482	0.0014	CcSEcCtD
Pimecrolimus—Influenza—Triamcinolone—ulcerative colitis	0.000482	0.0014	CcSEcCtD
Pimecrolimus—Vomiting—Mercaptopurine—ulcerative colitis	0.00048	0.00139	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.000476	0.00138	CcSEcCtD
Pimecrolimus—Rash—Mercaptopurine—ulcerative colitis	0.000476	0.00138	CcSEcCtD
Pimecrolimus—Dermatitis—Mercaptopurine—ulcerative colitis	0.000475	0.00138	CcSEcCtD
Pimecrolimus—Arthralgia—Azathioprine—ulcerative colitis	0.000469	0.00136	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000466	0.00135	CcSEcCtD
Pimecrolimus—Vomiting—Nicotine—ulcerative colitis	0.000465	0.00135	CcSEcCtD
Pimecrolimus—Bronchitis—Triamcinolone—ulcerative colitis	0.000464	0.00135	CcSEcCtD
Pimecrolimus—Rash—Nicotine—ulcerative colitis	0.000461	0.00134	CcSEcCtD
Pimecrolimus—Dermatitis—Nicotine—ulcerative colitis	0.000461	0.00134	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000459	0.00133	CcSEcCtD
Pimecrolimus—Angioedema—Mesalazine—ulcerative colitis	0.000458	0.00133	CcSEcCtD
Pimecrolimus—Headache—Nicotine—ulcerative colitis	0.000458	0.00133	CcSEcCtD
Pimecrolimus—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000457	0.00133	CcSEcCtD
Pimecrolimus—Infestation—Hydrocortisone—ulcerative colitis	0.000457	0.00133	CcSEcCtD
Pimecrolimus—Conjunctivitis—Prednisolone—ulcerative colitis	0.000454	0.00132	CcSEcCtD
Pimecrolimus—Paraesthesia—Budesonide—ulcerative colitis	0.000452	0.00131	CcSEcCtD
Pimecrolimus—Dyspnoea—Budesonide—ulcerative colitis	0.000449	0.0013	CcSEcCtD
Pimecrolimus—Nausea—Mercaptopurine—ulcerative colitis	0.000448	0.0013	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000448	0.0013	CcSEcCtD
Pimecrolimus—Infection—Azathioprine—ulcerative colitis	0.000447	0.0013	CcSEcCtD
Pimecrolimus—Cough—Mesalazine—ulcerative colitis	0.000438	0.00127	CcSEcCtD
Pimecrolimus—Skin disorder—Azathioprine—ulcerative colitis	0.000437	0.00127	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000435	0.00126	CcSEcCtD
Pimecrolimus—Nausea—Nicotine—ulcerative colitis	0.000434	0.00126	CcSEcCtD
Pimecrolimus—Pain—Budesonide—ulcerative colitis	0.000431	0.00125	CcSEcCtD
Pimecrolimus—Constipation—Budesonide—ulcerative colitis	0.000431	0.00125	CcSEcCtD
Pimecrolimus—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000429	0.00125	CcSEcCtD
Pimecrolimus—Infestation—Methylprednisolone—ulcerative colitis	0.000429	0.00125	CcSEcCtD
Pimecrolimus—Arthralgia—Mesalazine—ulcerative colitis	0.000427	0.00124	CcSEcCtD
Pimecrolimus—Face oedema—Prednisone—ulcerative colitis	0.000426	0.00124	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000424	0.00123	CcSEcCtD
Pimecrolimus—Conjunctivitis—Triamcinolone—ulcerative colitis	0.000418	0.00121	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000412	0.0012	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.00041	0.00119	CcSEcCtD
Pimecrolimus—Oedema—Mesalazine—ulcerative colitis	0.000409	0.00119	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000409	0.00119	CcSEcCtD
Pimecrolimus—Infection—Mesalazine—ulcerative colitis	0.000407	0.00118	CcSEcCtD
Pimecrolimus—Epistaxis—Triamcinolone—ulcerative colitis	0.000405	0.00118	CcSEcCtD
Pimecrolimus—Nervous system disorder—Mesalazine—ulcerative colitis	0.000402	0.00117	CcSEcCtD
Pimecrolimus—Urticaria—Budesonide—ulcerative colitis	0.0004	0.00116	CcSEcCtD
Pimecrolimus—Abdominal pain—Budesonide—ulcerative colitis	0.000398	0.00116	CcSEcCtD
Pimecrolimus—Body temperature increased—Budesonide—ulcerative colitis	0.000398	0.00116	CcSEcCtD
Pimecrolimus—Skin disorder—Mesalazine—ulcerative colitis	0.000398	0.00116	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000388	0.00113	CcSEcCtD
Pimecrolimus—Rhinitis—Triamcinolone—ulcerative colitis	0.000387	0.00112	CcSEcCtD
Pimecrolimus—Rhinitis—Methylprednisolone—ulcerative colitis	0.000386	0.00112	CcSEcCtD
Pimecrolimus—Pharyngitis—Triamcinolone—ulcerative colitis	0.000383	0.00111	CcSEcCtD
Pimecrolimus—Eye disorder—Hydrocortisone—ulcerative colitis	0.000383	0.00111	CcSEcCtD
Pimecrolimus—Conjunctivitis—Betamethasone—ulcerative colitis	0.000379	0.0011	CcSEcCtD
Pimecrolimus—Conjunctivitis—Dexamethasone—ulcerative colitis	0.000379	0.0011	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000373	0.00108	CcSEcCtD
Pimecrolimus—Hypersensitivity—Budesonide—ulcerative colitis	0.000371	0.00108	CcSEcCtD
Pimecrolimus—Immune system disorder—Hydrocortisone—ulcerative colitis	0.00037	0.00108	CcSEcCtD
Pimecrolimus—Paraesthesia—Mesalazine—ulcerative colitis	0.000368	0.00107	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000368	0.00107	CcSEcCtD
Pimecrolimus—Erythema—Prednisolone—ulcerative colitis	0.000365	0.00106	CcSEcCtD
Pimecrolimus—Dyspnoea—Mesalazine—ulcerative colitis	0.000365	0.00106	CcSEcCtD
Pimecrolimus—Eye disorder—Methylprednisolone—ulcerative colitis	0.00036	0.00105	CcSEcCtD
Pimecrolimus—Malnutrition—Hydrocortisone—ulcerative colitis	0.000357	0.00104	CcSEcCtD
Pimecrolimus—Erythema—Hydrocortisone—ulcerative colitis	0.000357	0.00104	CcSEcCtD
Pimecrolimus—Pruritus—Budesonide—ulcerative colitis	0.000356	0.00103	CcSEcCtD
Pimecrolimus—Body temperature increased—Azathioprine—ulcerative colitis	0.000355	0.00103	CcSEcCtD
Pimecrolimus—Abdominal pain—Azathioprine—ulcerative colitis	0.000355	0.00103	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000354	0.00103	CcSEcCtD
Pimecrolimus—Constipation—Mesalazine—ulcerative colitis	0.00035	0.00102	CcSEcCtD
Pimecrolimus—Pain—Mesalazine—ulcerative colitis	0.00035	0.00102	CcSEcCtD
Pimecrolimus—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000348	0.00101	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000347	0.00101	CcSEcCtD
Pimecrolimus—Diarrhoea—Budesonide—ulcerative colitis	0.000345	0.001	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000344	0.00176	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—ADCY5—ulcerative colitis	0.000343	0.00175	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TNF—ulcerative colitis	0.000342	0.00174	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—LTF—ulcerative colitis	0.000341	0.00174	CbGpPWpGaD
Pimecrolimus—Erythema—Triamcinolone—ulcerative colitis	0.000336	0.000976	CcSEcCtD
Pimecrolimus—Erythema—Methylprednisolone—ulcerative colitis	0.000335	0.000974	CcSEcCtD
Pimecrolimus—Malnutrition—Methylprednisolone—ulcerative colitis	0.000335	0.000974	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000335	0.000973	CcSEcCtD
Pimecrolimus—Angioedema—Prednisolone—ulcerative colitis	0.000334	0.00097	CcSEcCtD
Pimecrolimus—Hypersensitivity—Azathioprine—ulcerative colitis	0.000331	0.000962	CcSEcCtD
Pimecrolimus—MTOR—Signaling by NGF—CALM3—ulcerative colitis	0.000329	0.00168	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—MMP9—ulcerative colitis	0.000328	0.00167	CbGpPWpGaD
Pimecrolimus—Eye disorder—Dexamethasone—ulcerative colitis	0.000327	0.00095	CcSEcCtD
Pimecrolimus—Eye disorder—Betamethasone—ulcerative colitis	0.000327	0.00095	CcSEcCtD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—JAK2—ulcerative colitis	0.000327	0.00167	CbGpPWpGaD
Pimecrolimus—Angioedema—Hydrocortisone—ulcerative colitis	0.000326	0.000947	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—ulcerative colitis	0.000326	0.00166	CbGpPWpGaD
Pimecrolimus—Urticaria—Mesalazine—ulcerative colitis	0.000325	0.000945	CcSEcCtD
Pimecrolimus—Back pain—Triamcinolone—ulcerative colitis	0.000325	0.000944	CcSEcCtD
Pimecrolimus—MTOR—Signaling by NGF—RIPK2—ulcerative colitis	0.000324	0.00166	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—ulcerative colitis	0.000324	0.00166	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—IL6—ulcerative colitis	0.000324	0.00165	CbGpPWpGaD
Pimecrolimus—Body temperature increased—Mesalazine—ulcerative colitis	0.000324	0.00094	CcSEcCtD
Pimecrolimus—Abdominal pain—Mesalazine—ulcerative colitis	0.000324	0.00094	CcSEcCtD
Pimecrolimus—Vomiting—Budesonide—ulcerative colitis	0.00032	0.00093	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—TGFB1—ulcerative colitis	0.00032	0.00163	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—STAT3—ulcerative colitis	0.000319	0.00163	CbGpPWpGaD
Pimecrolimus—Rash—Budesonide—ulcerative colitis	0.000317	0.000922	CcSEcCtD
Pimecrolimus—Dermatitis—Budesonide—ulcerative colitis	0.000317	0.000921	CcSEcCtD
Pimecrolimus—MTOR—ErbB Signaling Pathway—TP53—ulcerative colitis	0.000317	0.00162	CbGpPWpGaD
Pimecrolimus—Headache—Budesonide—ulcerative colitis	0.000315	0.000916	CcSEcCtD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ADCY5—ulcerative colitis	0.000311	0.00159	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—JAK2—ulcerative colitis	0.000309	0.00158	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Azathioprine—ulcerative colitis	0.000308	0.000893	CcSEcCtD
Pimecrolimus—Angioedema—Triamcinolone—ulcerative colitis	0.000307	0.000892	CcSEcCtD
Pimecrolimus—MTOR—Signaling by Insulin receptor—JAK2—ulcerative colitis	0.000307	0.00157	CbGpPWpGaD
Pimecrolimus—Angioedema—Methylprednisolone—ulcerative colitis	0.000306	0.00089	CcSEcCtD
Pimecrolimus—MTOR—Immune System—HERC2—ulcerative colitis	0.000305	0.00156	CbGpPWpGaD
Pimecrolimus—Erythema—Betamethasone—ulcerative colitis	0.000305	0.000885	CcSEcCtD
Pimecrolimus—Erythema—Dexamethasone—ulcerative colitis	0.000305	0.000885	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—ulcerative colitis	0.000303	0.00155	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Mesalazine—ulcerative colitis	0.000302	0.000876	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000302	0.000876	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TP53—ulcerative colitis	0.000301	0.00154	CbGpPWpGaD
Pimecrolimus—Nausea—Budesonide—ulcerative colitis	0.000299	0.000869	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000299	0.00153	CbGpPWpGaD
Pimecrolimus—Oedema—Prednisolone—ulcerative colitis	0.000298	0.000866	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000298	0.000866	CcSEcCtD
Pimecrolimus—Cough—Triamcinolone—ulcerative colitis	0.000293	0.000851	CcSEcCtD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—STAT3—ulcerative colitis	0.000291	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—STAT3—ulcerative colitis	0.000291	0.00149	CbGpPWpGaD
Pimecrolimus—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000291	0.000846	CcSEcCtD
Pimecrolimus—Oedema—Hydrocortisone—ulcerative colitis	0.000291	0.000846	CcSEcCtD
Pimecrolimus—MTOR—Immune System—MASP2—ulcerative colitis	0.000291	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ICOSLG—ulcerative colitis	0.000291	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—ulcerative colitis	0.000291	0.00148	CbGpPWpGaD
Pimecrolimus—Pruritus—Mesalazine—ulcerative colitis	0.00029	0.000841	CcSEcCtD
Pimecrolimus—Infection—Hydrocortisone—ulcerative colitis	0.000289	0.00084	CcSEcCtD
Pimecrolimus—Vomiting—Azathioprine—ulcerative colitis	0.000286	0.00083	CcSEcCtD
Pimecrolimus—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000286	0.000829	CcSEcCtD
Pimecrolimus—Arthralgia—Methylprednisolone—ulcerative colitis	0.000285	0.000829	CcSEcCtD
Pimecrolimus—Eye disorder—Prednisone—ulcerative colitis	0.000285	0.000828	CcSEcCtD
Pimecrolimus—Rash—Azathioprine—ulcerative colitis	0.000283	0.000823	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000283	0.000823	CcSEcCtD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	0.000283	0.00145	CbGpPWpGaD
Pimecrolimus—Dermatitis—Azathioprine—ulcerative colitis	0.000283	0.000822	CcSEcCtD
Pimecrolimus—Flushing—Prednisone—ulcerative colitis	0.000283	0.000822	CcSEcCtD
Pimecrolimus—Skin disorder—Hydrocortisone—ulcerative colitis	0.000283	0.000821	CcSEcCtD
Pimecrolimus—Headache—Azathioprine—ulcerative colitis	0.000282	0.000818	CcSEcCtD
Pimecrolimus—Diarrhoea—Mesalazine—ulcerative colitis	0.00028	0.000814	CcSEcCtD
Pimecrolimus—Angioedema—Betamethasone—ulcerative colitis	0.000279	0.000809	CcSEcCtD
Pimecrolimus—Angioedema—Dexamethasone—ulcerative colitis	0.000279	0.000809	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL6—ulcerative colitis	0.000276	0.00141	CbGpPWpGaD
Pimecrolimus—Immune system disorder—Prednisone—ulcerative colitis	0.000275	0.0008	CcSEcCtD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000274	0.0014	CbGpPWpGaD
Pimecrolimus—Oedema—Triamcinolone—ulcerative colitis	0.000274	0.000796	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000274	0.000796	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000274	0.000795	CcSEcCtD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—ulcerative colitis	0.000273	0.00139	CbGpPWpGaD
Pimecrolimus—Infection—Triamcinolone—ulcerative colitis	0.000272	0.000791	CcSEcCtD
Pimecrolimus—Infection—Methylprednisolone—ulcerative colitis	0.000272	0.000789	CcSEcCtD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ulcerative colitis	0.00027	0.00138	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CHP1—ulcerative colitis	0.000269	0.00137	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000268	0.000779	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisolone—ulcerative colitis	0.000268	0.000778	CcSEcCtD
Pimecrolimus—Nausea—Azathioprine—ulcerative colitis	0.000267	0.000776	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—SEL1L—ulcerative colitis	0.000266	0.00136	CbGpPWpGaD
Pimecrolimus—Skin disorder—Methylprednisolone—ulcerative colitis	0.000266	0.000772	CcSEcCtD
Pimecrolimus—Erythema—Prednisone—ulcerative colitis	0.000265	0.000771	CcSEcCtD
Pimecrolimus—Malnutrition—Prednisone—ulcerative colitis	0.000265	0.000771	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000265	0.000771	CcSEcCtD
Pimecrolimus—MTOR—Signaling by SCF-KIT—JAK2—ulcerative colitis	0.000262	0.00134	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000261	0.000759	CcSEcCtD
Pimecrolimus—Vomiting—Mesalazine—ulcerative colitis	0.00026	0.000756	CcSEcCtD
Pimecrolimus—MTOR—AMPK Signaling—TP53—ulcerative colitis	0.00026	0.00133	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.00026	0.00133	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TNFRSF14—ulcerative colitis	0.00026	0.00132	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—DEFA5—ulcerative colitis	0.00026	0.00132	CbGpPWpGaD
Pimecrolimus—Rash—Mesalazine—ulcerative colitis	0.000258	0.00075	CcSEcCtD
Pimecrolimus—Dermatitis—Mesalazine—ulcerative colitis	0.000258	0.000749	CcSEcCtD
Pimecrolimus—MTOR—BDNF signaling pathway—JAK2—ulcerative colitis	0.000258	0.00132	CbGpPWpGaD
Pimecrolimus—Headache—Mesalazine—ulcerative colitis	0.000257	0.000745	CcSEcCtD
Pimecrolimus—Pain—Prednisolone—ulcerative colitis	0.000255	0.000741	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—ITGAL—ulcerative colitis	0.000254	0.0013	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—ulcerative colitis	0.000252	0.00129	CbGpPWpGaD
Pimecrolimus—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000251	0.00073	CcSEcCtD
Pimecrolimus—MTOR—Immune System—ARPC2—ulcerative colitis	0.000251	0.00128	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—JAK2—ulcerative colitis	0.000251	0.00128	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.00025	0.000726	CcSEcCtD
Pimecrolimus—MTOR—BDNF signaling pathway—RELA—ulcerative colitis	0.00025	0.00128	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000249	0.000724	CcSEcCtD
Pimecrolimus—Pain—Hydrocortisone—ulcerative colitis	0.000249	0.000723	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.000249	0.00127	CbGpPWpGaD
Pimecrolimus—Oedema—Dexamethasone—ulcerative colitis	0.000249	0.000723	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000249	0.000723	CcSEcCtD
Pimecrolimus—Oedema—Betamethasone—ulcerative colitis	0.000249	0.000723	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000249	0.000723	CcSEcCtD
Pimecrolimus—Infection—Dexamethasone—ulcerative colitis	0.000247	0.000718	CcSEcCtD
Pimecrolimus—Infection—Betamethasone—ulcerative colitis	0.000247	0.000718	CcSEcCtD
Pimecrolimus—MTOR—Signaling by ERBB4—JAK2—ulcerative colitis	0.000247	0.00126	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Triamcinolone—ulcerative colitis	0.000246	0.000715	CcSEcCtD
Pimecrolimus—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000246	0.000713	CcSEcCtD
Pimecrolimus—Dyspnoea—Triamcinolone—ulcerative colitis	0.000244	0.00071	CcSEcCtD
Pimecrolimus—MTOR—Immune System—IL1R2—ulcerative colitis	0.000244	0.00125	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Betamethasone—ulcerative colitis	0.000244	0.000709	CcSEcCtD
Pimecrolimus—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000244	0.000709	CcSEcCtD
Pimecrolimus—MTOR—ErbB1 downstream signaling—STAT3—ulcerative colitis	0.000244	0.00124	CbGpPWpGaD
Pimecrolimus—Nausea—Mesalazine—ulcerative colitis	0.000243	0.000706	CcSEcCtD
Pimecrolimus—FKBP1A—Disease—SLC11A1—ulcerative colitis	0.000243	0.00124	CbGpPWpGaD
Pimecrolimus—Angioedema—Prednisone—ulcerative colitis	0.000243	0.000705	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—CCR6—ulcerative colitis	0.000241	0.00123	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—ADCY5—ulcerative colitis	0.000239	0.00122	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000238	0.000692	CcSEcCtD
Pimecrolimus—Urticaria—Prednisolone—ulcerative colitis	0.000237	0.000688	CcSEcCtD
Pimecrolimus—MTOR—Downstream signal transduction—JAK2—ulcerative colitis	0.000236	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—JAK2—ulcerative colitis	0.000235	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—JAK2—ulcerative colitis	0.000235	0.0012	CbGpPWpGaD
Pimecrolimus—Pain—Triamcinolone—ulcerative colitis	0.000234	0.000681	CcSEcCtD
Pimecrolimus—MTOR—Signaling by ERBB2—JAK2—ulcerative colitis	0.000234	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—JAK2—ulcerative colitis	0.000232	0.00119	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000232	0.00119	CbGpPWpGaD
Pimecrolimus—Urticaria—Hydrocortisone—ulcerative colitis	0.000231	0.000672	CcSEcCtD
Pimecrolimus—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00023	0.000669	CcSEcCtD
Pimecrolimus—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00023	0.000669	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—FCGR2A—ulcerative colitis	0.00023	0.00117	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000227	0.000658	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000227	0.000658	CcSEcCtD
Pimecrolimus—Arthralgia—Prednisone—ulcerative colitis	0.000226	0.000656	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—ulcerative colitis	0.000226	0.00115	CbGpPWpGaD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000224	0.000652	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000224	0.00065	CcSEcCtD
Pimecrolimus—Paraesthesia—Dexamethasone—ulcerative colitis	0.000223	0.000649	CcSEcCtD
Pimecrolimus—Paraesthesia—Betamethasone—ulcerative colitis	0.000223	0.000649	CcSEcCtD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—ulcerative colitis	0.000222	0.00113	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Prednisolone—ulcerative colitis	0.00022	0.000638	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCR1—ulcerative colitis	0.000219	0.00112	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—JAK2—ulcerative colitis	0.000219	0.00112	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—JAK2—ulcerative colitis	0.000219	0.00112	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—JAK2—ulcerative colitis	0.000219	0.00112	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—MAML2—ulcerative colitis	0.000218	0.00111	CbGpPWpGaD
Pimecrolimus—Urticaria—Triamcinolone—ulcerative colitis	0.000218	0.000633	CcSEcCtD
Pimecrolimus—Urticaria—Methylprednisolone—ulcerative colitis	0.000217	0.000631	CcSEcCtD
Pimecrolimus—Body temperature increased—Triamcinolone—ulcerative colitis	0.000217	0.00063	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR—JAK2—ulcerative colitis	0.000217	0.00111	CbGpPWpGaD
Pimecrolimus—Oedema—Prednisone—ulcerative colitis	0.000217	0.000629	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisone—ulcerative colitis	0.000217	0.000629	CcSEcCtD
Pimecrolimus—MTOR—Signaling by SCF-KIT—MMP9—ulcerative colitis	0.000217	0.00111	CbGpPWpGaD
Pimecrolimus—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000216	0.000628	CcSEcCtD
Pimecrolimus—Infection—Prednisone—ulcerative colitis	0.000215	0.000625	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000215	0.000624	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000215	0.000624	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—JAK2—ulcerative colitis	0.000215	0.0011	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000215	0.000623	CcSEcCtD
Pimecrolimus—MTOR—Signaling by PDGF—JAK2—ulcerative colitis	0.000214	0.00109	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SEL1L—ulcerative colitis	0.000214	0.00109	CbGpPWpGaD
Pimecrolimus—Pain—Betamethasone—ulcerative colitis	0.000213	0.000618	CcSEcCtD
Pimecrolimus—Pain—Dexamethasone—ulcerative colitis	0.000213	0.000618	CcSEcCtD
Pimecrolimus—Nervous system disorder—Prednisone—ulcerative colitis	0.000212	0.000617	CcSEcCtD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—ulcerative colitis	0.000212	0.00108	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CARD9—ulcerative colitis	0.000212	0.00108	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—NFKB1—ulcerative colitis	0.000211	0.00108	CbGpPWpGaD
Pimecrolimus—Skin disorder—Prednisone—ulcerative colitis	0.00021	0.000611	CcSEcCtD
Pimecrolimus—MTOR—Immune System—IL7R—ulcerative colitis	0.000207	0.00106	CbGpPWpGaD
Pimecrolimus—Pruritus—Hydrocortisone—ulcerative colitis	0.000206	0.000598	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	0.000205	0.00105	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000203	0.000591	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000203	0.000591	CcSEcCtD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	0.000203	0.00104	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000202	0.000587	CcSEcCtD
Pimecrolimus—MTOR—IRS-mediated signalling—IL6—ulcerative colitis	0.000202	0.00103	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000202	0.000585	CcSEcCtD
Pimecrolimus—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000199	0.000579	CcSEcCtD
Pimecrolimus—Urticaria—Dexamethasone—ulcerative colitis	0.000198	0.000574	CcSEcCtD
Pimecrolimus—Urticaria—Betamethasone—ulcerative colitis	0.000198	0.000574	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000197	0.000573	CcSEcCtD
Pimecrolimus—Abdominal pain—Dexamethasone—ulcerative colitis	0.000197	0.000571	CcSEcCtD
Pimecrolimus—Abdominal pain—Betamethasone—ulcerative colitis	0.000197	0.000571	CcSEcCtD
Pimecrolimus—Body temperature increased—Betamethasone—ulcerative colitis	0.000197	0.000571	CcSEcCtD
Pimecrolimus—Body temperature increased—Dexamethasone—ulcerative colitis	0.000197	0.000571	CcSEcCtD
Pimecrolimus—MTOR—IRS-related events—IL6—ulcerative colitis	0.000196	0.001	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—RELA—ulcerative colitis	0.000196	0.001	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Prednisone—ulcerative colitis	0.000195	0.000565	CcSEcCtD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—ulcerative colitis	0.000194	0.000992	CbGpPWpGaD
Pimecrolimus—Pruritus—Triamcinolone—ulcerative colitis	0.000194	0.000563	CcSEcCtD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—JAK2—ulcerative colitis	0.000194	0.000989	CbGpPWpGaD
Pimecrolimus—Pruritus—Methylprednisolone—ulcerative colitis	0.000194	0.000562	CcSEcCtD
Pimecrolimus—MTOR—Signaling by SCF-KIT—STAT3—ulcerative colitis	0.000193	0.000983	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL20—ulcerative colitis	0.000192	0.000981	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—LTF—ulcerative colitis	0.000192	0.000978	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—STAT3—ulcerative colitis	0.000189	0.000966	CbGpPWpGaD
Pimecrolimus—MTOR—IGF1R signaling cascade—IL6—ulcerative colitis	0.000189	0.000966	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin receptor signalling cascade—IL6—ulcerative colitis	0.000189	0.000966	CbGpPWpGaD
Pimecrolimus—Rash—Prednisolone—ulcerative colitis	0.000188	0.000546	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—CALM3—ulcerative colitis	0.000188	0.000959	CbGpPWpGaD
Pimecrolimus—Dermatitis—Prednisolone—ulcerative colitis	0.000188	0.000545	CcSEcCtD
Pimecrolimus—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000187	0.000544	CcSEcCtD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—ulcerative colitis	0.000187	0.000955	CbGpPWpGaD
Pimecrolimus—Headache—Prednisolone—ulcerative colitis	0.000187	0.000542	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—ulcerative colitis	0.000186	0.000949	CbGpPWpGaD
Pimecrolimus—Constipation—Prednisone—ulcerative colitis	0.000185	0.000538	CcSEcCtD
Pimecrolimus—Vomiting—Hydrocortisone—ulcerative colitis	0.000185	0.000538	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—RIPK2—ulcerative colitis	0.000185	0.000945	CbGpPWpGaD
Pimecrolimus—Rash—Hydrocortisone—ulcerative colitis	0.000184	0.000533	CcSEcCtD
Pimecrolimus—Dermatitis—Hydrocortisone—ulcerative colitis	0.000183	0.000533	CcSEcCtD
Pimecrolimus—Headache—Hydrocortisone—ulcerative colitis	0.000182	0.00053	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—GNA12—ulcerative colitis	0.000181	0.000923	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CALM3—ulcerative colitis	0.00018	0.000921	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CALM3—ulcerative colitis	0.00018	0.000917	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—ulcerative colitis	0.000179	0.000912	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—RIPK2—ulcerative colitis	0.000178	0.000907	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000177	0.000515	CcSEcCtD
Pimecrolimus—Nausea—Prednisolone—ulcerative colitis	0.000177	0.000514	CcSEcCtD
Pimecrolimus—Pruritus—Betamethasone—ulcerative colitis	0.000176	0.000511	CcSEcCtD
Pimecrolimus—Pruritus—Dexamethasone—ulcerative colitis	0.000176	0.000511	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—CTLA4—ulcerative colitis	0.000175	0.000894	CbGpPWpGaD
Pimecrolimus—Vomiting—Triamcinolone—ulcerative colitis	0.000174	0.000506	CcSEcCtD
Pimecrolimus—Vomiting—Methylprednisolone—ulcerative colitis	0.000174	0.000505	CcSEcCtD
Pimecrolimus—MTOR—Downstream signal transduction—STAT3—ulcerative colitis	0.000173	0.000884	CbGpPWpGaD
Pimecrolimus—Nausea—Hydrocortisone—ulcerative colitis	0.000173	0.000502	CcSEcCtD
Pimecrolimus—Rash—Triamcinolone—ulcerative colitis	0.000173	0.000502	CcSEcCtD
Pimecrolimus—Dermatitis—Triamcinolone—ulcerative colitis	0.000173	0.000502	CcSEcCtD
Pimecrolimus—Rash—Methylprednisolone—ulcerative colitis	0.000172	0.000501	CcSEcCtD
Pimecrolimus—Dermatitis—Methylprednisolone—ulcerative colitis	0.000172	0.000501	CcSEcCtD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—ulcerative colitis	0.000172	0.000879	CbGpPWpGaD
Pimecrolimus—Urticaria—Prednisone—ulcerative colitis	0.000172	0.0005	CcSEcCtD
Pimecrolimus—Headache—Triamcinolone—ulcerative colitis	0.000172	0.000499	CcSEcCtD
Pimecrolimus—Headache—Methylprednisolone—ulcerative colitis	0.000171	0.000498	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCR2—ulcerative colitis	0.000171	0.000875	CbGpPWpGaD
Pimecrolimus—Abdominal pain—Prednisone—ulcerative colitis	0.000171	0.000497	CcSEcCtD
Pimecrolimus—Body temperature increased—Prednisone—ulcerative colitis	0.000171	0.000497	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—ulcerative colitis	0.00017	0.000869	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Betamethasone—ulcerative colitis	0.00017	0.000494	CcSEcCtD
Pimecrolimus—Diarrhoea—Dexamethasone—ulcerative colitis	0.00017	0.000494	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—NOD2—ulcerative colitis	0.000168	0.000856	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	0.000168	0.000856	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD79A—ulcerative colitis	0.000167	0.000853	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD14—ulcerative colitis	0.000167	0.000851	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—NFKB1—ulcerative colitis	0.000165	0.000844	CbGpPWpGaD
Pimecrolimus—Nausea—Triamcinolone—ulcerative colitis	0.000163	0.000473	CcSEcCtD
Pimecrolimus—Nausea—Methylprednisolone—ulcerative colitis	0.000162	0.000472	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CCR6—ulcerative colitis	0.000161	0.000822	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—STAT3—ulcerative colitis	0.00016	0.000819	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Prednisone—ulcerative colitis	0.00016	0.000464	CcSEcCtD
Pimecrolimus—MTOR—Signaling by VEGF—IL6—ulcerative colitis	0.000158	0.000808	CbGpPWpGaD
Pimecrolimus—Vomiting—Betamethasone—ulcerative colitis	0.000158	0.000459	CcSEcCtD
Pimecrolimus—Vomiting—Dexamethasone—ulcerative colitis	0.000158	0.000459	CcSEcCtD
Pimecrolimus—MTOR—Signaling by Insulin receptor—IL6—ulcerative colitis	0.000157	0.000802	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—STAT3—ulcerative colitis	0.000157	0.000801	CbGpPWpGaD
Pimecrolimus—Rash—Betamethasone—ulcerative colitis	0.000157	0.000456	CcSEcCtD
Pimecrolimus—Rash—Dexamethasone—ulcerative colitis	0.000157	0.000456	CcSEcCtD
Pimecrolimus—Dermatitis—Dexamethasone—ulcerative colitis	0.000157	0.000455	CcSEcCtD
Pimecrolimus—Dermatitis—Betamethasone—ulcerative colitis	0.000157	0.000455	CcSEcCtD
Pimecrolimus—Headache—Betamethasone—ulcerative colitis	0.000156	0.000453	CcSEcCtD
Pimecrolimus—Headache—Dexamethasone—ulcerative colitis	0.000156	0.000453	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—VCAM1—ulcerative colitis	0.000155	0.000789	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ITGAL—ulcerative colitis	0.000154	0.000788	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DQA1—ulcerative colitis	0.000154	0.000787	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—RELA—ulcerative colitis	0.000154	0.000785	CbGpPWpGaD
Pimecrolimus—Pruritus—Prednisone—ulcerative colitis	0.000153	0.000445	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—MAML2—ulcerative colitis	0.000153	0.00078	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SEL1L—ulcerative colitis	0.00015	0.000763	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—JAK2—ulcerative colitis	0.000149	0.00076	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Prednisone—ulcerative colitis	0.000148	0.000431	CcSEcCtD
Pimecrolimus—Nausea—Betamethasone—ulcerative colitis	0.000148	0.000429	CcSEcCtD
Pimecrolimus—Nausea—Dexamethasone—ulcerative colitis	0.000148	0.000429	CcSEcCtD
Pimecrolimus—MTOR—Immune System—IRF5—ulcerative colitis	0.000147	0.000749	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.000146	0.000744	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CXCL8—ulcerative colitis	0.000145	0.00074	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—RELA—ulcerative colitis	0.000144	0.000736	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—ulcerative colitis	0.000142	0.000726	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTGER4—ulcerative colitis	0.000142	0.000724	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IRF8—ulcerative colitis	0.00014	0.000715	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CCR6—ulcerative colitis	0.00014	0.000715	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	0.000139	0.00071	CbGpPWpGaD
Pimecrolimus—Vomiting—Prednisone—ulcerative colitis	0.000138	0.0004	CcSEcCtD
Pimecrolimus—Rash—Prednisone—ulcerative colitis	0.000137	0.000397	CcSEcCtD
Pimecrolimus—MTOR—Disease—SLC11A1—ulcerative colitis	0.000136	0.000697	CbGpPWpGaD
Pimecrolimus—Dermatitis—Prednisone—ulcerative colitis	0.000136	0.000396	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—ADCY5—ulcerative colitis	0.000136	0.000696	CbGpPWpGaD
Pimecrolimus—Headache—Prednisone—ulcerative colitis	0.000136	0.000394	CcSEcCtD
Pimecrolimus—MTOR—Signaling by SCF-KIT—IL6—ulcerative colitis	0.000134	0.000686	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—FCGR2A—ulcerative colitis	0.000134	0.000683	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—ADCY5—ulcerative colitis	0.00013	0.000665	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GHRL—ulcerative colitis	0.00013	0.000663	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—NFKB1—ulcerative colitis	0.00013	0.000662	CbGpPWpGaD
Pimecrolimus—Nausea—Prednisone—ulcerative colitis	0.000129	0.000374	CcSEcCtD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—ulcerative colitis	0.000129	0.000657	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTPN2—ulcerative colitis	0.000128	0.000654	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—ulcerative colitis	0.000127	0.000646	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CALM3—ulcerative colitis	0.000126	0.000642	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RIPK2—ulcerative colitis	0.000124	0.000632	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCR1—ulcerative colitis	0.000123	0.000629	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—MAML2—ulcerative colitis	0.000123	0.000626	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—NFKB1—ulcerative colitis	0.000122	0.000621	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—ulcerative colitis	0.000121	0.000617	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—ulcerative colitis	0.00012	0.000614	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—ulcerative colitis	0.00012	0.000611	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—ulcerative colitis	0.000119	0.000609	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—ulcerative colitis	0.000119	0.000608	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—STAT3—ulcerative colitis	0.000117	0.000595	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TLR4—ulcerative colitis	0.000114	0.000584	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	0.000112	0.000572	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—ulcerative colitis	0.000112	0.000572	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—ulcerative colitis	0.000112	0.000572	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—ulcerative colitis	0.000111	0.000567	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—ulcerative colitis	0.00011	0.000562	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DRB1—ulcerative colitis	0.00011	0.00056	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—ulcerative colitis	0.00011	0.00056	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CALM3—ulcerative colitis	0.000109	0.000559	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—STAT3—ulcerative colitis	0.000109	0.000558	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL20—ulcerative colitis	0.000108	0.000552	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RIPK2—ulcerative colitis	0.000108	0.00055	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ADRB2—ulcerative colitis	0.000107	0.000549	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTLA4—ulcerative colitis	0.000106	0.000542	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ICAM1—ulcerative colitis	0.000105	0.000537	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GNA12—ulcerative colitis	0.000102	0.000519	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD79A—ulcerative colitis	0.000101	0.000517	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CALM3—ulcerative colitis	0.000101	0.000516	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	9.93e-05	0.000507	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NOD2—ulcerative colitis	9.77e-05	0.000499	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD14—ulcerative colitis	9.71e-05	0.000496	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCR2—ulcerative colitis	9.64e-05	0.000492	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—VCAM1—ulcerative colitis	9.37e-05	0.000479	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQA1—ulcerative colitis	9.35e-05	0.000477	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CDH1—ulcerative colitis	9.31e-05	0.000475	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ADCY5—ulcerative colitis	9.12e-05	0.000466	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR6—ulcerative colitis	9.06e-05	0.000463	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—TP53—ulcerative colitis	8.89e-05	0.000454	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MAML2—ulcerative colitis	8.59e-05	0.000439	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—JAK2—ulcerative colitis	8.5e-05	0.000434	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—RELA—ulcerative colitis	8.23e-05	0.00042	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—ulcerative colitis	8.14e-05	0.000416	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—JAK2—ulcerative colitis	8.12e-05	0.000415	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD4—ulcerative colitis	8.05e-05	0.000411	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTGER4—ulcerative colitis	7.98e-05	0.000407	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ADCY5—ulcerative colitis	7.94e-05	0.000405	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—RELA—ulcerative colitis	7.9e-05	0.000403	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD4—ulcerative colitis	7.73e-05	0.000395	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD4—ulcerative colitis	7.7e-05	0.000393	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTGS2—ulcerative colitis	7.64e-05	0.00039	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—ulcerative colitis	7.64e-05	0.00039	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ADCY5—ulcerative colitis	7.33e-05	0.000374	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GHRL—ulcerative colitis	7.3e-05	0.000373	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CALM3—ulcerative colitis	7.07e-05	0.000361	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RIPK2—ulcerative colitis	6.97e-05	0.000356	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—ulcerative colitis	6.94e-05	0.000355	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—NFKB1—ulcerative colitis	6.94e-05	0.000354	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—NFKB1—ulcerative colitis	6.66e-05	0.00034	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR4—ulcerative colitis	6.66e-05	0.00034	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DRB1—ulcerative colitis	6.65e-05	0.00034	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ICAM1—ulcerative colitis	6.38e-05	0.000326	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADRB2—ulcerative colitis	6.05e-05	0.000309	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CHP1—ulcerative colitis	5.97e-05	0.000305	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—STAT3—ulcerative colitis	5.96e-05	0.000304	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—JAK2—ulcerative colitis	5.69e-05	0.00029	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CDH1—ulcerative colitis	5.64e-05	0.000288	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—ulcerative colitis	5.53e-05	0.000282	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RELA—ulcerative colitis	5.51e-05	0.000281	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL8—ulcerative colitis	5.19e-05	0.000265	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—DLD—ulcerative colitis	5.15e-05	0.000263	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADCY5—ulcerative colitis	5.13e-05	0.000262	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2—ulcerative colitis	4.96e-05	0.000253	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—JAK2—ulcerative colitis	4.95e-05	0.000253	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFNG—ulcerative colitis	4.86e-05	0.000248	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RELA—ulcerative colitis	4.79e-05	0.000245	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP9—ulcerative colitis	4.7e-05	0.00024	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD4—ulcerative colitis	4.69e-05	0.000239	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NFKB1—ulcerative colitis	4.65e-05	0.000237	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—JAK2—ulcerative colitis	4.57e-05	0.000233	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—ulcerative colitis	4.36e-05	0.000222	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—ulcerative colitis	4.33e-05	0.000221	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD4—ulcerative colitis	4.33e-05	0.000221	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2—ulcerative colitis	4.32e-05	0.00022	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—ulcerative colitis	4.3e-05	0.000219	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—STAT3—ulcerative colitis	4.18e-05	0.000213	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—ulcerative colitis	4.16e-05	0.000213	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NFKB1—ulcerative colitis	4.04e-05	0.000206	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—ulcerative colitis	3.87e-05	0.000198	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—STAT3—ulcerative colitis	3.63e-05	0.000185	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—STAT3—ulcerative colitis	3.35e-05	0.000171	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—JAK2—ulcerative colitis	3.2e-05	0.000163	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TP53—ulcerative colitis	3.19e-05	0.000163	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—ulcerative colitis	3.11e-05	0.000159	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RELA—ulcerative colitis	3.1e-05	0.000158	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL8—ulcerative colitis	2.92e-05	0.000149	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—ulcerative colitis	2.92e-05	0.000149	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2—ulcerative colitis	2.79e-05	0.000142	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP9—ulcerative colitis	2.64e-05	0.000135	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NFKB1—ulcerative colitis	2.61e-05	0.000133	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—ulcerative colitis	2.54e-05	0.00013	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.49e-05	0.000127	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STAT3—ulcerative colitis	2.35e-05	0.00012	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—ulcerative colitis	2.34e-05	0.00012	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.24e-05	0.000115	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—ulcerative colitis	2.18e-05	0.000111	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TP53—ulcerative colitis	1.79e-05	9.15e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.74e-05	8.91e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—ulcerative colitis	1.64e-05	8.37e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.63e-05	8.31e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.21e-05	6.2e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—ulcerative colitis	1.09e-05	5.57e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—ulcerative colitis	9.55e-06	4.88e-05	CbGpPWpGaD
